APOPTOSIS-INDUCING AGENTS FOR TREATING CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Russian patent published in 2015 - IPC C07C311/51 C07D209/08 C07D213/71 C07D231/56 C07D235/04 C07D265/36 C07D285/22 C07D295/155 C07D311/14 A61K31/635 A61K31/353 A61K31/404 A61K31/416 A61K31/4184 A61P35/00 

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to specific compounds or their therapeutically acceptable salts presented in the patent claim and representing sulphonyl benzamide derivatives. Besides, the invention refers to a pharmaceutical composition and a method of treating bladder cancer, brain cancer, breast cancer, bone marrow cancer, cervical cancer, chronic lymphocytic leukemia, colorectal cancer, stomach cancer, hepatocellular carcinoma, lymphoblastic leukemia, follicular lymphoma, T-cell or B-cell lymphoid process, melanoma, myelogenic leukaemia, myeloma, oral cancer, ovarian cancer, non-small-cell lung cancer, prostate cancer, small-cell lung cancer, spleen cancer with the above composition containing an excipient and a therapeutically effective amount of the sulphonyl benzamide derivative or its therapeutically acceptable salt.

EFFECT: preparing the new pharmaceutical composition.

5 cl, 45 ex